Last reviewed · How we verify
Influenza vaccination with PPV23 — Competitive Intelligence Brief
marketed
Biologic
Live · refreshed every 30 min
Target snapshot
Influenza vaccination with PPV23 (Influenza vaccination with PPV23) — Korea University Guro Hospital.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Influenza vaccination with PPV23 TARGET | Influenza vaccination with PPV23 | Korea University Guro Hospital | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Influenza vaccination with PPV23 CI watch — RSS
- Influenza vaccination with PPV23 CI watch — Atom
- Influenza vaccination with PPV23 CI watch — JSON
- Influenza vaccination with PPV23 alone — RSS
Cite this brief
Drug Landscape (2026). Influenza vaccination with PPV23 — Competitive Intelligence Brief. https://druglandscape.com/ci/influenza-vaccination-with-ppv23. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab